8.30 Introduction Fábryová Ľ, Dukát A, Češka R.

08.40–09.55 Epidemiology, ethiopatogenesis and risk factors of atherosclerosis Chairmen: Dukát A, Češka R.

08.40–09.05 Long-term trends of cardiovascular disease risk factors in Slovak Republic Kamenský G.1, Avdičová M.2

V. interná klinika, Oddelenie neinvazívnej kardiovaskulárnej diagnostiky, Univerzitná nemocnica Bratislava, Slovak Republic1;

Regionálny úrad verejného zdravotníctva, Banská Bystrica, Slovak Republic2

09.05–09.30 Etiopathogenesis of atherosclerosis Bernadič M. Ústav patologickej fyziológie LFUK Bratislava, Slovak Republic 09.30–10.00 Risk factor of atherosclerosis – lipids and lipoproteins in relationship to atherosclerosis Češka R. III. interní klinika 1. LF UK a VFN, Praha, Czech Republic

10.00–10.20 Coffee break

10.20–12.40 Non-pharmacology and farmacology therapy of dyslipidaemias Chairmen: Sirotiaková J, Pella D.

10.20–10.40 Lifestyle recommendation in therapy of dyslipidaemias Szabo M.

Diabetologická ambulance, Městská nemocnice ALMEDA, a.s., Neratovice, Czech Republic

10.40–11.10 Statins and ezetimibe Sirotiaková J. Oddelenie vnútorného lekárstva, NsP Levice, Slovak Republic

11.10–11.40 Fibrates and omega-3 fatty acids Pella D. III. Interná klinika UPJŠ LF a UNLP, Košice, Slovak Republic

11.40–12.10 Hypolipidemic therapy with niacin in management of patients with high cardiovascular risk Dukát A. II. interná klinika LFUK, Univerzitná nemocnica Bratislava, Slovak Republic

12.10–12.40 Combined hypolipidemic therapy Fábryová Ľ. Metabol KLINIK s.r.o., Ambulancia pre diabetológiu, poruchy látkovej premeny a výživy, Špecializovaná lipidologická ambulancia, Bratislava, Slovak Republic

12.40–13.40 Lunch break

13.40–14.55 Therapy of dyslipidaemias at special populations Chairmen: Fábryová Ľ, Vrablík M.

13.40–13.55 Acute coronary syndrom and statins: which, when, which doses and how long? Hricák V. Oddelenie akútnej kardiológie, NÚSCH, Bratislava, Slovak Republic

13.55–14.10 Hypolipidemic therapy in prevention of stroke Vrablík M.

III. interní klinika 1. LF UK a VFN, Praha, Czech Republic

14.10–14.25 Importance of hypolipidemic therapy in patient with arterial hypertension S. Filipová1; D. Škultétyová2

Kardiologická klinika LF SZU a NÚSCH, Bratislava, Slovak Republic1; Odd. neinvazívnej kardiológie, Kardiologická klinika NÚSCH, Bratislava, Slovak Republic2

14.25–14.40 Actual recommendations for therapy of dyslipidaemias in women Murín J. I. Interná klinika, Univerzitná nemocnica Bratislava, Slovak Republic

14.40–14.55 Hypolipidemic therapy in patients with hepatal diseases Jarčuška P. I. interná klinika LF UPJŠ a UNLP, Košice, Slovak Republic

14.55–15.10 Coffee break

15.10–16.00 Interactive education (case reports) Chairmen: Rajecová E, Čaprnda M.

15.10–16.00 Mistakes at diagnosis and therapy of dyslipidaemias (case reports) Vrablík M. III. interní klinika 1. LF UK a VFN, Praha, Czech Republic

16.00–16.15 Discussion

Conclusion Fábryová Ľ, Dukát A, Češka R.

SCIENTIFIC PROGRAM

6 SACCME credits

Organizational CommitteeMUDr. Ľubomíra Fábryová, PhD.

prof. MUDr. Andrej Dukát, CSc.

prof. MUDr. Daniel Pella, PhD.

MUDr. Eva Rajecová

Scientific Programme CommitteeMUDr. Ľubomíra Fábryová, PhD.

prof. MUDr. Andrej Dukát, CSc.

prof. MUDr. Richard Češka, CSc.

prof. MUDr. Daniel Pella, PhD.

MUDr. Eva Rajecová

Main partnerAbbott Laboratories Slovakia s. r. o.

Medial partnersLekárske Listy

SAMEDI s.r.o.

Organisation and technical supportFARMI-PROFI, spol. s r.o.

online registration:www.saa.sk(since 5th December 2010 to 28th January 2011)

We are looking forward to meet you

MUDr. Ľubomíra Fábryová, PhD.President of SAA

hotel CITYSeberíniho 9821 03 Bratislava

CZECH SOCIETY FOR ATHEROSCLEROSIS

FACULTY OF MEDICINE COMENIUS UNIVERSITY BRATISLAVA

LIPID SECTION SLOVAK SOCIETY OF DIABETOLOGY

invites you to attend

SCHOOL OF LIPIDOLOGY

Bratislava • 9th February 2011

CITY hotelSeberíniho 9, 821 03 Bratislava, Slovak Republic